These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29483182)

  • 1. A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome.
    Kanter JE; Kramer F; Barnhart S; Duggan JM; Shimizu-Albergine M; Kothari V; Chait A; Bouman SD; Hamerman JA; Hansen BF; Olsen GS; Bornfeldt KE
    Diabetes; 2018 May; 67(5):946-959. PubMed ID: 29483182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the insulin receptor by an insulin mimetic peptide.
    Park J; Li J; Mayer JP; Ball KA; Wu J; Hall C; Accili D; Stowell MHB; Bai XC; Choi E
    Nat Commun; 2022 Sep; 13(1):5594. PubMed ID: 36151101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulator.
    Wu M; Dai G; Yao J; Hoyt S; Wang L; Mu J
    PLoS One; 2015; 10(3):e0122012. PubMed ID: 25799496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-mimetic peptides (TXM) inhibit inflammatory pathways associated with high-glucose and oxidative stress.
    Lejnev K; Khomsky L; Bokvist K; Mistriel-Zerbib S; Naveh T; Farb TB; Alsina-Fernandez J; Atlas D
    Free Radic Biol Med; 2016 Oct; 99():557-571. PubMed ID: 27658743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
    Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
    Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/Lymphotoxin β-Receptor pathway.
    Andrés-Blasco I; Vinué Á; Herrero-Cervera A; Martínez-Hervás S; Nuñez L; Piqueras L; Ascaso JF; Sanz MJ; Burks DJ; González-Navarro H
    Thromb Haemost; 2016 Aug; 116(2):379-93. PubMed ID: 27172975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Delivered Human Biliverdin Reductase-Based Peptide Increases Glucose Uptake by Activating IRK/Akt/GSK3 Axis: The Peptide Is Effective in the Cell and Wild-Type and Diabetic Ob/Ob Mice.
    Gibbs PE; Miralem T; Lerner-Marmarosh N; Maines MD
    J Diabetes Res; 2016; 2016():4712053. PubMed ID: 27294151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway.
    Lu J; Zeng Y; Hou W; Zhang S; Li L; Luo X; Xi W; Chen Z; Xiang M
    J Nutr Biochem; 2012 Nov; 23(11):1449-57. PubMed ID: 22278080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
    Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
    Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Treatment With XMetA Activates Hepatic Insulin Receptors and Lowers Blood Glucose in Normal Mice.
    Bedinger DH; Kieffer DA; Goldfine ID; Roell MK; Adams SH
    J Cell Biochem; 2015 Sep; 116(9):2109-19. PubMed ID: 25808283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pathway coupling of the activated insulin receptor drives signaling selectivity by XMetA, an allosteric partial agonist antibody.
    Bedinger DH; Goldfine ID; Corbin JA; Roell MK; Adams SH
    J Pharmacol Exp Ther; 2015 Apr; 353(1):35-43. PubMed ID: 25613982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis.
    Rotllan N; Chamorro-Jorganes A; Araldi E; Wanschel AC; Aryal B; Aranda JF; Goedeke L; Salerno AG; Ramírez CM; Sessa WC; Suárez Y; Fernández-Hernando C
    FASEB J; 2015 Feb; 29(2):597-610. PubMed ID: 25392271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice.
    Taguchi K; Matsumoto T; Kamata K; Kobayashi T
    Pharmacol Res; 2012 Jan; 65(1):56-65. PubMed ID: 21933713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin improves response to glucose tolerance test in control and diabetic rats.
    López-Soldado I; Niisuke K; Veiga C; Adrover A; Manzano A; Martínez-Redondo V; Camps M; Bartrons R; Zorzano A; Gumà A
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E440-51. PubMed ID: 26714846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the insulin receptor (IR) by insulin and a synthetic peptide has different effects on gene expression in IR-transfected L6 myoblasts.
    Jensen M; Palsgaard J; Borup R; de Meyts P; Schäffer L
    Biochem J; 2008 Jun; 412(3):435-45. PubMed ID: 18318661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
    Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
    Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.